Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Triggiani

Showing results (61-70 of 146) with videos related to

Pageof 15
Sort By:
Biochimica Et Biophysica Acta|January 10, 2009
Expression of phospholipases A2 in primary human lung macrophages: role of cytosolic phospholipase A2-alpha in arachidonic acid release and platelet activating factor synthesisGiorgio Giannattasio, Ying Lai, Francescopaolo Granata, et al.
The Journal of Allergy and Clinical Immunology|December 12, 2018
Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: A Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & ImmunologyMelody C Carter, Dean D Metcalfe, Almudena Matito, et al.
Frontiers in Immunology|February 22, 2020
Enhanced Expression of CD47 Is Associated With Off-Target Resistance to Tyrosine Kinase Inhibitor Gefitinib in NSCLCAnnunziata Nigro, Luca Ricciardi, Ilaria Salvato, et al.
Journal of Clinical Medicine|July 24, 2021
Antiphospholipid Antibodies and Heart Failure with Preserved Ejection Fraction. The Multicenter ATHERO-APS StudyDaniele Pastori, Paul R J Ames, Massimo Triggiani, et al.
Internal and Emergency Medicine|September 5, 2013
Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian expertsMarco Cicardi, Paolo Bellis, Giuliano Bertazzoni, et al.
Thrombosis Research|October 12, 2023
Low-grade endotoxemia and risk of recurrent thrombosis in primary antiphospholipid syndrome. The multicenter ATHERO-APS studyTommaso Bucci, Paul R J Ames, Vittoria Cammisotto, et al.
International Journal of Molecular Sciences|September 27, 2025
Comprehensive Profiling of Cytokines and Growth Factors: Pathogenic Roles and Clinical Applications in Autoimmune DiseasesAnna Donniacuo, Arianna Mauro, Chiara Cardamone, et al.
International Journal of Molecular Sciences|December 2, 2020
Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized MedicinePeter Valent, Cem Akin, Boguslaw Nedoszytko, et al.
International Archives of Allergy and Immunology|July 1, 2019
Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation SyndromePeter Valent, Patrizia Bonadonna, Karin Hartmann, et al.
European Journal of Internal Medicine|July 27, 2023
Thymic stromal lymphopoietin (TSLP) is a substrate for tryptase in patients with mastocytosisSimone Marcella, Angelica Petraroli, Luisa Canè, et al.
Pageof 15

Showing results (61-70 of 146) with videos related to

Sort By:
Pageof 15
Biochimica Et Biophysica Acta|January 10, 2009
Expression of phospholipases A2 in primary human lung macrophages: role of cytosolic phospholipase A2-alpha in arachidonic acid release and platelet activating factor synthesisGiorgio Giannattasio, Ying Lai, Francescopaolo Granata, et al.
The Journal of Allergy and Clinical Immunology|December 12, 2018
Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: A Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & ImmunologyMelody C Carter, Dean D Metcalfe, Almudena Matito, et al.
Frontiers in Immunology|February 22, 2020
Enhanced Expression of CD47 Is Associated With Off-Target Resistance to Tyrosine Kinase Inhibitor Gefitinib in NSCLCAnnunziata Nigro, Luca Ricciardi, Ilaria Salvato, et al.
Journal of Clinical Medicine|July 24, 2021
Antiphospholipid Antibodies and Heart Failure with Preserved Ejection Fraction. The Multicenter ATHERO-APS StudyDaniele Pastori, Paul R J Ames, Massimo Triggiani, et al.
Internal and Emergency Medicine|September 5, 2013
Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian expertsMarco Cicardi, Paolo Bellis, Giuliano Bertazzoni, et al.
Thrombosis Research|October 12, 2023
Low-grade endotoxemia and risk of recurrent thrombosis in primary antiphospholipid syndrome. The multicenter ATHERO-APS studyTommaso Bucci, Paul R J Ames, Vittoria Cammisotto, et al.
International Journal of Molecular Sciences|September 27, 2025
Comprehensive Profiling of Cytokines and Growth Factors: Pathogenic Roles and Clinical Applications in Autoimmune DiseasesAnna Donniacuo, Arianna Mauro, Chiara Cardamone, et al.
International Journal of Molecular Sciences|December 2, 2020
Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized MedicinePeter Valent, Cem Akin, Boguslaw Nedoszytko, et al.
International Archives of Allergy and Immunology|July 1, 2019
Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation SyndromePeter Valent, Patrizia Bonadonna, Karin Hartmann, et al.
European Journal of Internal Medicine|July 27, 2023
Thymic stromal lymphopoietin (TSLP) is a substrate for tryptase in patients with mastocytosisSimone Marcella, Angelica Petraroli, Luisa Canè, et al.
Pageof 15